CyberKnife radiation therapy for malignant myopericytoma in a pediatric patient: a case report and review of the literature [0.03%]
儿科患者恶性肌周细胞瘤的 CyberKnife 放射治疗一例报告及文献复习
Bence Bukovszky,Júlia Vízkeleti,Levente Jánváry et al.
Bence Bukovszky et al.
It has a very poor prognosis due to its aggressive nature and frequent distant metastases.
Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma [0.03%]
基于cOFM-HILIC-HRMS平台的胶质母细胞瘤脑内微环境原位实时监测技术
Fernanda Monedeiro,Denise Schimek,Eva-Maria Prugger et al.
Fernanda Monedeiro et al.
Background: Glioblastoma exhibits a very poor prognosis and profound metabolic alterations associated to its aggressiveness. Examining tumor metabolic states is crucial for identifying potential therapeutic targets, enabling personalized medicine applications.
[Leptomeningeal disease in breast cancer: State of the art and future directions] [0.03%]
乳腺癌脑膜转移的现状及未来方向
Louis Larrouquere,Emilie Clement,Marie Pierre Sunyach et al.
Louis Larrouquere et al.
Historically associated with a very poor prognosis and survival measured in weeks, their management has evolved considerably.
Molecular mechanism detection of stage I to stage II transition of esophageal squamous cell carcinoma: a system biology approach [0.03%]
食管鳞癌I期到II期演进的分子机制检测：系统生物学方法
Mitra Rezaei,Fatemeh Bandarian,Farideh Razi et al.
Mitra Rezaei et al.
Background: Esophageal cancer (EC) is recognized as cancer with a very poor prognosis and malignancy.
Promising Treatment Strategy for Primary Malignant Melanoma of the Esophagus by Radical Esophagectomy and Nivolumab as Adjuvant Therapy: A Case Report [0.03%]
内镜全食管切除联合纳武单抗辅助治疗原发性食道恶性黑色素瘤一例报告
Yusuke Yamamoto,Junya Kitadani,Keiji Hayata et al.
Yusuke Yamamoto et al.
Introduction: Primary malignant melanoma of the esophagus (PMME) is a rare malignant tumor of the esophagus with very poor prognosis due to high rates of recurrence and metastasis even after radical resection.
Case Reports
Surgical case reports. 2025;11(1):25-0027. DOI:10.70352/scrj.cr.25-0027 2025
Characterizing long- and short-survival glioblastoma patients with FLT-PET/MRI and metabolomics [0.03%]
结合FLT-PET/MRI和代谢组学的胶质母细胞瘤病人长期生存与短期生存的特征研究
Jan Axelsson,Benny Björkblom,Thomas Asklund et al.
Jan Axelsson et al.
Patients with glioblastoma have a very poor prognosis despite multimodal interventions.
Transcription factor BACH1 promotes epithelial-mesenchymal transition by repressing iron metabolism-related genes [0.03%]
转录因子BACH1通过抑制铁代谢相关基因促进上皮间质转化效应
Shuichiro Hayashi,Mitsuyo Matsumoto,Liang Liu et al.
Shuichiro Hayashi et al.
Pancreatic adenocarcinoma (PDAC) is one of the cancers with a very poor prognosis for its highly invasive and metastatic ability.
Long-Term Follow-Up of Omental Cranial Transposition to Bypass the Blood-Brain Barrier for Recurrent Glioblastoma: A Case Report and Scientific Rationale [0.03%]
腹膜cranial转位长期随访以 bypass 血脑屏障治疗复发性胶质母细胞瘤：病例报告及科学依据
Souvik Singha,Julianna Cavallaro,Tamika Wong et al.
Souvik Singha et al.
Recurrent glioblastoma multiforme (GBM) is associated with a very poor prognosis due to the limited efficacy of existing therapies and constraints of blood-brain barrier (BBB) permeability. Particularly in the recurrent setting, there is no uniform standard of care treatment.
Case Reports
Cureus. 2025 Apr 1;17(4):e81566. DOI:10.7759/cureus.81566 2025
Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer [0.03%]
胃癌中单核细胞向巨噬细胞分化相关基因作为预后生物标志物的鉴定与验证
Suyang Bai,Zhaofeng Chen,Rui Ji et al.
Suyang Bai et al.
Background: Gastric cancer (GC) has a very poor prognosis as most cases are diagnosed at a late stage, which can be partially attributed to a lack of reliable diagnostic biomarkers.
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach [0.03%]
从遗传学视角和联合治疗策略看肺癌免疫治疗中的耐药及应对措施
Paweł Zieliński,Maria Stępień,Hanna Chowaniec et al.
Paweł Zieliński et al.
Lung cancer with the highest number of new cases diagnosed in Europe and in Poland, remains an example of malignancy with a very poor prognosis despite the recent progress in medicine.
耗时 0.34826 秒，为您在
48229835
条记录里面共找到 1169 篇文章 [XML]